Standard Biotools (LAB) Capital Expenditures (2010 - 2026)
Standard Biotools (LAB) posted quarterly Capital Expenditures of $319000.0 for Q1 2026, down 93.69% year-over-year from $5.1 million in Q1 2025, and down 55.45% quarter-over-quarter from $716000.0 in Q4 2025.
Standard Biotools (LAB) Capital Expenditures (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Capital Expenditures for 17 consecutive years, with $319000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 93.69% year-over-year to $319000.0; the TTM figure through Mar 2026 stood at -$3.9 million (down 163.81% YoY), while the FY2025 annual figure was $851000.0, down 53.09% from the prior year.
- Capital Expenditures retreated to $319000.0 in Q1 2026 per LAB's latest filing, from $716000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $5.1 million in Q1 2025 and bottomed at -$4.9 million in Q2 2025.
- Historically, Capital Expenditures has averaged $400529.4 across 5 years, with a median of $781000.0 in 2024.
- On a YoY basis, Capital Expenditures climbed as much as 547.12% in 2025 and fell as far as 523.69% in 2025.
- Standard Biotools' Capital Expenditures stood at $755000.0 in 2022, then plunged by 464.64% to -$2.8 million in 2023, then slipped by 14.75% to -$3.2 million in 2024, then soared by 122.67% to $716000.0 in 2025, then tumbled by 55.45% to $319000.0 in 2026.
- Business Quant data shows LAB's Capital Expenditures at $319000.0 in Q1 2026, $716000.0 in Q4 2025, and -$48000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Standard Biotools | 250.59 Mn | -226.13 Mn | 10.54 Mn | 344,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 344,000.00 |
| Jun 30, 2026 | 344,000.00 |
| Mar 31, 2026 | 319,000.00 |
| Mar 31, 2026 | 319,000.00 |
| Dec 31, 2025 | 716,000.00 |
| Dec 31, 2025 | 716,000.00 |
| Sep 30, 2025 | -48,000.00 |
| Sep 30, 2025 | -48,000.00 |
| Jun 30, 2025 | -4.87 Mn |
| Jun 30, 2025 | -4.87 Mn |
| Mar 31, 2025 | 5.05 Mn |
| Mar 31, 2025 | 5.05 Mn |
| Dec 31, 2024 | -3.16 Mn |
| Dec 31, 2024 | -3.16 Mn |
| Sep 30, 2024 | 4.97 Mn |
| Sep 30, 2024 | 4.97 Mn |
| Jun 30, 2024 | -781,000.00 |
| Jun 30, 2024 | -781,000.00 |
| Mar 31, 2024 | 781,000.00 |
| Mar 31, 2024 | 781,000.00 |